1. Cerebral microbleeds and risk of adverse outcomes in patients with atrial fibrillation: a systematic review and meta-analysis. (14th October 2021) Authors: Corica, B; Romiti, G.F; Raparelli, V; Cangemi, R; Basili, S; Proietti, M Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical outcomes related to fasting plasma glucose variability, history of diabetes mellitus and antidiabetic regimens in patients with atrial fibrillation: a subgroup analysis from the SPORTIF trial. (25th November 2020) Authors: Proietti, M; Gumprecht, J; Farcomeni, A; Romiti, G.F; Lip, G.Y.H Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prevalence and impact of frailty in patients with atrial fibrillation: a systematic review and meta-analysis. (14th October 2021) Authors: Proietti, M; Romiti, G.F; Raparelli, V; Diemberger, I; Boriani, G; Marzetti, E; Lip, G.Y.H; Cesari, M Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Prognostic impact of renal function trajectories and temporal variability amongst anticoagulated atrial fibrillation patients: a subgroup analysis of the SPORTIF III and V trials. (25th November 2020) Authors: Proietti, M; Gumprecht, J; Romiti, G.F; Lip, G.Y.H Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗